Tissue-engineered Fascia from Vaginal Fibroblasts for Patients Needing Reconstructive Pelvic Surgery

Overview

Journal Int Urogynecol J

Publisher Springer

Specialties Gynecology & Obstetrics
Urology

Date 2010 May 19

PMID 20480140

Citations 14

Authors

Man-Jung Hung

Mei-Chin Wen

Chia-Nung Hung

Esther Shih-Chu Ho

Gin-Den Chen

Vivian Cheng Yang

Affiliations

Soon will be listed here.

Abstract

Introduction And Hypothesis: Mesh-augmented reconstructive surgery for pelvic organ prolapse (POP) does not meet clinical expectations. A tissue-engineered fascia equivalent needs to be developed.

Methods: Human vaginal fibroblasts (HVFs) from 10 patients were characterized in vitro. Eligible HVFs and a biodegradable scaffold were used to fabricate a fascia equivalent, which was then transplanted in vivo.

Results: The cultured HVFs were divided into high (n = 6) or low (n = 4) collagen I/III ratio groups. Cells of the high-ratio group exhibited significantly higher proliferation potential than those of the low-ratio group (P < 0.05). A fascia equivalent was made with HVFs of the high-ratio group. In the subsequent animal study, a well-organized neo-fascia formation containing HVFs could be traced up to 12 weeks after transplantation.

Conclusions: Our results suggest that a tissue-engineered fascia could be developed from HVFs in vitro and in vivo, which might be an effective treatment for POP in the future.

Citing Articles

Reproducibility and Consistency of Isolation Protocols for Fibroblasts, Smooth Muscle Cells, and Epithelial Cells from the Human Vagina.

Sueters J, Schipperheijn R, Huirne J, Smit T, Guler Z Cells. 2025; 14(2).

PMID: 39851504 PMC: 11763730. DOI: 10.3390/cells14020076.

Promoting cell proliferation and collagen production with ascorbic acid 2-phosphate-releasing poly(l-lactide-co-ε-caprolactone) membranes for treating pelvic organ prolapse.

Kurki A, Paakinaho K, Hannula M, Karjalainen S, Kuismanen K, Hyttinen J Regen Biomater. 2024; 11:rbae060.

PMID: 38903561 PMC: 11187500. DOI: 10.1093/rb/rbae060.

Ascorbic Acid 2-Phosphate Releasing Supercritically Foamed Porous Poly-L-Lactide-Co-ε-Caprolactone Scaffold Enhances the Collagen Production of Human Vaginal Stromal Cells: A New Approach for Vaginal Tissue Engineering.

Sartoneva R, Paakinaho K, Hannula M, Kuismanen K, Huhtala H, Hyttinen J Tissue Eng Regen Med. 2023; 21(1):81-96.

PMID: 37907765 PMC: 10764701. DOI: 10.1007/s13770-023-00603-3.

Extracellular Matrix-Based and Electrospun Scaffolding Systems for Vaginal Reconstruction.

Farzamfar S, Elia E, Richer M, Chabaud S, Naji M, Bolduc S Bioengineering (Basel). 2023; 10(7).

PMID: 37508817 PMC: 10376078. DOI: 10.3390/bioengineering10070790.

Cell-based endometrial regeneration: current status and future perspectives.

Keyhanvar N, Zarghami N, Bleisinger N, Hajipour H, Fattahi A, Nouri M Cell Tissue Res. 2021; 384(2):241-254.

PMID: 33650018 DOI: 10.1007/s00441-021-03419-6.

References

Olsen A, Smith V, Bergstrom J, Colling J, Clark A . Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997; 89(4):501-6. DOI: 10.1016/S0029-7844(97)00058-6. View

Jia X, Glazener C, Mowatt G, MacLennan G, Bain C, Fraser C . Efficacy and safety of using mesh or grafts in surgery for anterior and/or posterior vaginal wall prolapse: systematic review and meta-analysis. BJOG. 2008; 115(11):1350-61. DOI: 10.1111/j.1471-0528.2008.01845.x. View

Lee C, Moioli E, Mao J . Fibroblastic differentiation of human mesenchymal stem cells using connective tissue growth factor. Conf Proc IEEE Eng Med Biol Soc. 2007; 2006:775-8. PMC: 4035038. DOI: 10.1109/IEMBS.2006.259866. View

Rosch R, Klinge U, Si Z, Junge K, Klosterhalfen B, Schumpelick V . A role for the collagen I/III and MMP-1/-13 genes in primary inguinal hernia?. BMC Med Genet. 2002; 3:2. PMC: 65699. DOI: 10.1186/1471-2350-3-2. View

Zheng H, Si Z, Kasperk R, Bhardwaj R, Schumpelick V, Klinge U . Recurrent inguinal hernia: disease of the collagen matrix?. World J Surg. 2002; 26(4):401-8. DOI: 10.1007/s00268-001-0239-5. View

De Filippo R, Yoo J, Atala A . Engineering of vaginal tissue in vivo. Tissue Eng. 2003; 9(2):301-6. DOI: 10.1089/107632703764664765. View

Carr L, Steele D, Steele S, Wagner D, Pruchnic R, Jankowski R . 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008; 19(6):881-3. DOI: 10.1007/s00192-007-0553-z. View

Nakanishi Y, Chen G, Komuro H, Ushida T, Kaneko S, Tateishi T . Tissue-engineered urinary bladder wall using PLGA mesh-collagen hybrid scaffolds: a comparison study of collagen sponge and gel as a scaffold. J Pediatr Surg. 2003; 38(12):1781-4. DOI: 10.1016/j.jpedsurg.2003.08.034. View

Weiss R, Weiss M, Beasley K, Munavalli G . Autologous cultured fibroblast injection for facial contour deformities: a prospective, placebo-controlled, Phase III clinical trial. Dermatol Surg. 2007; 33(3):263-8. DOI: 10.1111/j.1524-4725.2007.33060.x. View

10.

Zong W, Zyczynski H, Meyn L, Gordy S, Moalli P . Regulation of MMP-1 by sex steroid hormones in fibroblasts derived from the female pelvic floor. Am J Obstet Gynecol. 2007; 196(4):349.e1-11. DOI: 10.1016/j.ajog.2006.12.019. View

11.

Atala A, Bauer S, Soker S, Yoo J, Retik A . Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet. 2006; 367(9518):1241-6. DOI: 10.1016/S0140-6736(06)68438-9. View

12.

Bhatia N, Ho M . Stem cell therapy for urinary incontinence and pelvic floor disorders: a novel approach. Curr Opin Obstet Gynecol. 2004; 16(5):397-8. DOI: 10.1097/00001703-200410000-00007. View

13.

Makinen J, Kahari V, Soderstrom K, Vuorio E, Hirvonen T . Collagen synthesis in the vaginal connective tissue of patients with and without uterine prolapse. Eur J Obstet Gynecol Reprod Biol. 1987; 24(4):319-25. DOI: 10.1016/0028-2243(87)90157-2. View

14.

Zong W, Meyn L, Moalli P . The amount and activity of active matrix metalloproteinase 13 is suppressed by estradiol and progesterone in human pelvic floor fibroblasts. Biol Reprod. 2008; 80(2):367-74. PMC: 2804822. DOI: 10.1095/biolreprod.108.072462. View

15.

Mitterberger M, Marksteiner R, Margreiter E, Pinggera G, Colleselli D, Frauscher F . Autologous myoblasts and fibroblasts for female stress incontinence: a 1-year follow-up in 123 patients. BJU Int. 2007; 100(5):1081-5. DOI: 10.1111/j.1464-410X.2007.07119.x. View

16.

Baessler K, Maher C . Mesh augmentation during pelvic-floor reconstructive surgery: risks and benefits. Curr Opin Obstet Gynecol. 2006; 18(5):560-6. DOI: 10.1097/01.gco.0000242961.48114.b0. View

17.

Segev Y, Auslender R, Feiner B, Lissak A, Lavie O, Abramov Y . Are women with pelvic organ prolapse at a higher risk of developing hernias?. Int Urogynecol J Pelvic Floor Dysfunct. 2009; 20(12):1451-3. DOI: 10.1007/s00192-009-0968-9. View

18.

Silva W, Karram M . Scientific basis for use of grafts during vaginal reconstructive procedures. Curr Opin Obstet Gynecol. 2005; 17(5):519-29. DOI: 10.1097/01.gco.0000180156.64879.00. View

19.

Bump R, Norton P . Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am. 1999; 25(4):723-46. DOI: 10.1016/s0889-8545(05)70039-5. View

20.

Chen G, Sato T, Ohgushi H, Ushida T, Tateishi T, Tanaka J . Culturing of skin fibroblasts in a thin PLGA-collagen hybrid mesh. Biomaterials. 2004; 26(15):2559-66. DOI: 10.1016/j.biomaterials.2004.07.034. View